Price:
Rs. 12,000.00
Sample Type: EDTA Whole Blood
Fasting Not Required
Notes: N8199
Frequently Asked Questions (FAQ's):
What does the NextGen IRMA test include?
It includes analysis of key cancer-related genes, mutations, fusions, and genomic markers relevant for targeted therapy planning.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses next-generation sequencing (NGS) platforms with strict quality controls and expert bioinformatics to generate accurate molecular reports.
Who should undergo this test?
Patients diagnosed with solid tumors or hematological cancers who require precision treatment guidance and therapy selection.
Why is the NextGen IRMA test important in cancer management?
It helps identify actionable genetic alterations that can influence therapy response and improve treatment outcomes.
What type of sample is needed for this test?
Tumor tissue or liquid biopsy (blood) may be used depending on clinical suitability and availability.
Do I need special preparation before the sample collection?
No specific preparation or fasting is required for this test.
How long does Metropolis Healthcare take to provide the report?
Results are typically available within 10–14 working days, depending on the type and quality of the specimen.
Does Metropolis Healthcare offer guidance for interpreting results?
Yes, specialized oncopathology experts at Metropolis Healthcare assist clinicians in understanding results and recommending follow-up options